Trial intelligence / Profile preview

Weekly Radiation and Taxotere for Advanced NSCLC

NCT00256789Phase 2Completed

Start
Sep 2002
Primary completion
Dec 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC). Started Sep 2002; status: completed.

02

Drugs

docetaxel
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00256789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00256789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call